日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comparison of Viable and Heat-Inactivated Lacticaseibacillus rhamnosusIDCC 3201: Anti-Pathogenic, Anti-Inflammatory, and Microbiota Modulating Effect

活性与热灭活的鼠李糖乳杆菌IDCC 3201的比较:抗病原体、抗炎和微生物群调节作用

Kim, Hayoung; Lee, Hanbin; Bang, Won Yeong; Park, Haeseong; Moon, Jin Seok

Efficacy of Neratinib-Based Therapy in ERBB2-Mutant Lung Adenocarcinomas: Findings From 2 International Phase 2 Studies

奈拉替尼治疗ERBB2突变型肺腺癌的疗效:两项国际II期研究的结果

Li, Bob T; Gandhi, Leena; Ravichandran, Vignesh; Besse, Benjamin; Mazières, Julien; Shapiro, Geoffrey I; Boni, Valentina; Waqar, Saiama N; Park, Haeseong; Quinn, David I; Martinez, Alejandro; Stemmer, Salomon M; Cortot, Alexis B; Barlesi, Fabrice; Quoix, Elisabeth; Burkard, Mark E; Selcuklu, S Duygu; Hunt, Casey; Donoghue, Mark T A; Kris, Mark G; Bebchuk, Judith; Eli, Lisa D; McCulloch, Leanne; Solit, David B; Jänne, Pasi A

Effects of a spore-forming probiotic blend on bowel habits and physical well-being in adults with functional constipation: A randomized, double-blind, placebo-controlled trial

产孢益生菌混合物对功能性便秘成人患者排便习惯和身体健康的影响:一项随机、双盲、安慰剂对照试验

Park, Hyung Gyu; Lee, Han Bin; Lee, Minjee; Park, Haeseong; Kang, Minji; Bok, Minkyung; Hwang, Yeongtaek; Jeong, Kyuho; Maeng, Sungho; Lim, Hyunjung; Moon, Jin Seok

Targeting Esophageal Cancer: Promising Drugs for the Clinical Landscape and Key Knowledge Gaps

食管癌靶向治疗:临床应用前景广阔的药物及关键知识缺口

Akumaga, Terzungwe; Park, Haeseong; Lockhart, A Craig; Jin, Ramon U

Modulation of HER2 internalization enhances single-dose antibody-drug potency in HER2(+) gastric cancer.

调节 HER2 内化可增强单剂量抗体药物对 HER2(+) 胃癌的疗效

Zidel Abbey, Benton Alex, Brown Emma, Shmuel Shayla, Vanover Alex, Panikar Sandeep Surendra, Bose Ron, Park Haeseong, Davis Andrew A, Pereira Patrícia M R

VEGFR2 blockade overcomes acquired KRAS G12D inhibitor resistance driven by PI3Kγ activation

VEGFR2阻断可克服由PI3Kγ激活驱动的获得性KRAS G12D抑制剂耐药性。

Hwang, Sung-Hyun; Bae, Mingyun; Kim, Ji-Won; Hyun, Seung Yoon; Kim, Kui-Jin; Choe, Joshua H; Kim, Min Jung; Park, Ji Won; Jeong, Seung-Yong; Choi, Songji; Park, Woochan; Seo, Jeongmin; Chae, Heejung; Kang, Minsu; Jung, Eun Hee; Suh, Koung Jin; Kim, Se Hyun; Kim, Jin Won; Kim, Yu Jung; Kim, Jee Hyun; Park, Haeseong; Aguirre, Andrew J; Lee, Eunjung Alice; Ku, Ja-Lok; Lee, Keun-Wook

First-in-Human Dose-Escalation Study of Fianlimab, an Antilymphocyte Activation Gene-3 Antibody, with Cemiplimab in Patients with Advanced Malignancies

首次人体剂量递增研究:抗淋巴细胞活化基因-3抗体Fianlimab联合Cemiplimab治疗晚期恶性肿瘤患者

Lakhani, Nehal J; Papadopoulos, Kyriakos P; Johnson, Melissa Lynne; Park, Haeseong; Wang, Ding; Yap, Timothy A; Dowlati, Afshin; Maki, Robert G; Ulahannan, Susanna; Lynce, Filipa; Kelly, Karen; Williamson, Stephen; Malhotra, Jyoti; Chen, Shuquan; Gonzalez Ortiz, Ana; Jankovic, Vladimir; Paccaly, Anne; Masinde, Sheila; Mani, Jayakumar; Lowy, Israel; Gullo, Giuseppe; Sims, Tasha; Kroog, Glenn

PD-L1 has a heterogeneous and dynamic expression in gastric cancer with implications for immunoPET.

PD-L1 在胃癌中具有异质性和动态表达,这对免疫PET具有重要意义

Ibrahim Dina, Simó Cristina, Brown Emma L, Shmuel Shayla, Panikar Sandeep Surendra, Benton Alex, DeWeerd Rachel, Dehdashti Farrokh, Park Haeseong, Pereira Patrícia M R

Ramucirumab plus FOLFIRI or irinotecan as second-line treatment for patients with gastroesophageal adenocarcinoma: a review and meta-analysis of an emerging option

雷莫芦单抗联合FOLFIRI或伊立替康作为胃食管腺癌患者的二线治疗:一项新兴治疗方案的综述和荟萃分析

Park, Haeseong; Klempner, Samuel J; Chao, Joseph; Wainberg, Zev A; Lukanowski, Mariusz; Chenji, Suresh; Bourke, Shannon; Chatterjee, Anindya; Lorenzen, Sylvie

Phase 1b study to assess the safety, tolerability, and clinical activity of pamiparib in combination with temozolomide in patients with locally advanced or metastatic solid tumors

一项评估帕米帕利联合替莫唑胺治疗局部晚期或转移性实体瘤患者的安全性、耐受性和临床活性的 1b 期研究

Stradella, Agostina; Johnson, Melissa; Goel, Sanjay; Park, Haeseong; Lakhani, Nehal; Arkenau, Hendrik-Tobias; Galsky, Matthew D; Calvo, Emiliano; Baz, Vicente; Moreno, Victor; Saavedra, Omar; Luen, Stephen J; Mu, Song; Wan, Qiting; Chang, Victoria; Zhang, Wa; Barve, Minal